Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure's blue ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...
Marks the first Medicare coverage decision for Veracyte’s whole-genome sequencing-based TrueMRD platform and launch of the first test Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics ...
Cellens, a Boston, MA-based cancer diagnostics startup, has raised a $6.5 million seed round. The company is developing a mechanobiology and AI-driven platform, BioFeel, for non-invasive cancer ...
The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood ...
2don MSN
39% of women with bladder cancer were first told they had a UTI – these are the 9 symptoms to know
A consultant urologist explains why bladder cancer is often mistaken for a urinary tract infection in women – and the warning ...
Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results